Cargando…

YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer

BACKGROUND: YKL-40 is a secreted inflammatory protein that its overexpression has been reported to correlate with poor outcome of various malignant diseases, especially in cancer. However, the function of this protein is still unclear. METHODS: The clinical prognosis of non-small cell lung cancers (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jefri, Malvin, Huang, Yi-Ning, Huang, Wen-Chien, Tai, Chun-San, Chen, Wen-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537570/ https://www.ncbi.nlm.nih.gov/pubmed/26275425 http://dx.doi.org/10.1186/s12885-015-1592-3

Ejemplares similares

YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition
por: Hao, Hailong, et al.
Publicado: (2021)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Increased YKL-40 levels are linked with disease severity of initially diagnosed Graves’ disease
por: Chen, Yi-Ding, et al.
Publicado: (2023)

GGCT promotes colorectal cancer migration and invasion via epithelial-mesenchymal transition
por: Huang, Qi, et al.
Publicado: (2020)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

YKL-40 in the diagnosis, prediction of prognosis, and platinum sensitivity in serous epithelial ovarian cancer
por: Kahramanoğlu, İlker, et al.
Publicado: (2018)

Serum YKL-40 Level Is Associated with the Chemotherapy Response and Prognosis of Patients with Small Cell Lung Cancer
por: Xu, Chun-Hua, et al.
Publicado: (2014)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Adiponectin inhibits migration and invasion by reversing epithelial-mesenchymal transition in non-small cell lung carcinoma
por: Cui, Enhai, et al.
Publicado: (2018)

YKL-40/CHI3L1 facilitates migration and invasion in HER2 overexpressing breast epithelial progenitor cells and generates a niche for capillary-like network formation
por: Morera, Erika, et al.
Publicado: (2019)

Laminin-332 mediates proliferation, apoptosis, invasion, migration and epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma
por: Huang, Caiqun, et al.
Publicado: (2021)

Expression of the Chitinase Family Glycoprotein YKL-40 in Undifferentiated, Differentiated and Trans-Differentiated Mesenchymal Stem Cells
por: Hoover, Daniel J., et al.
Publicado: (2013)

Role of breast regression protein-39/YKL-40 in asthma and allergic responses
por: Lee, Chun Geun, et al.
Publicado: (2010)

NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
por: Zhang, Yi, et al.
Publicado: (2018)

MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1
por: Shi, Ying, et al.
Publicado: (2021)

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014)

Active legumain promotes invasion and migration of neuroblastoma by regulating epithelial-mesenchymal transition
por: Zhang, Min, et al.
Publicado: (2022)

FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition
por: Zhang, Xiang, et al.
Publicado: (2019)

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
por: Shao, Rong, et al.
Publicado: (2009)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013)

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
por: Shao, Rong, et al.
Publicado: (2015)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)

Effect of Vitamin D on YKL-40: Rat Hypercholesterolemia Model
por: Kocabas, Rahim
Publicado: (2023)

Circ_0049447 acts as a tumor suppressor in gastric cancer through reducing proliferation, migration, invasion, and epithelial-mesenchymal transition
por: Tang, Kai-Wen, et al.
Publicado: (2021)

Correction: Expression of the Chitinase Family Glycoprotein YKL-40 in Undifferentiated, Differentiated and Trans-Differentiated Mesenchymal Stem Cells
Publicado: (2014)

Paeonol Inhibits Pancreatic Cancer Cell Migration and Invasion Through the Inhibition of TGF-β1/Smad Signaling and Epithelial-Mesenchymal-Transition
por: Cheng, Chien-Shan, et al.
Publicado: (2020)

Epithelial-mesenchymal Transition and Cell Invasion
por: Son, Hwajin, et al.
Publicado: (2010)

YKL-40-Induced Inhibition of miR-590-3p Promotes Interleukin-18 Expression and Angiogenesis of Endothelial Progenitor Cells
por: Li, Te-Mao, et al.
Publicado: (2017)

p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells
por: Hou, Xue, et al.
Publicado: (2018)

miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion
por: Chen, Dahu, et al.
Publicado: (2014)

FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition
por: Ogunbolude, Yetunde, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2mq3e05413s9bu3k2fgv4s3rhm